Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kimberly Wilkins is active.

Publication


Featured researches published by Kimberly Wilkins.


The Journal of Infectious Diseases | 2012

Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246 and CMX001

Edith R. Lederman; Whitni Davidson; Harold L. Groff; Scott K. Smith; Tyler Warkentien; Yu Li; Kimberly Wilkins; Kevin L. Karem; Rama Akondy; Rafi Ahmed; Michael Frace; Wun-Ju Shieh; Sherif R. Zaki; Dennis E. Hruby; Wendy Painter; Kimberly L. Bergman; Jeffrey I. Cohen; Inger K. Damon

Progressive vaccinia (PV) is a rare but potentially lethal complication that develops in smallpox vaccine recipients with severely impaired cellular immunity. We describe a patient with PV who required treatment with vaccinia immune globulin and who received 2 investigational agents, ST-246 and CMX001. We describe the various molecular, pharmacokinetic, and immunologic studies that provided guidance to escalate and then successfully discontinue therapy. Despite development of resistance to ST-246 during treatment, the patient had resolution of PV. This case demonstrates the need for continued development of novel anti-orthopoxvirus pharmaceuticals and the importance of both intensive and timely clinical and laboratory support in management of PV.


Journal of Virological Methods | 2013

Specific qPCR assays for the detection of orf virus, pseudocowpox virus and bovine papular stomatitis virus

Hui Zhao; Kimberly Wilkins; Inger K. Damon; Yu Li

The genus Parapoxvirus (PAPV) is comprised traditionally of orf virus (ORFV), pseudocowpox virus (PCPV) and bovine papular stomatitis virus (BPSV), which cause infections of ruminants and their handlers in the U.S. and worldwide. Unlike orthopoxvirus infections, which can cause systemic or localized infections, PAPV infections present normally as benign, self-limited and localized skin lesions; infections do not confer lifelong immunity. In recent years, related potentially to enhanced awareness and the availability of diagnostic methods, there has been an observed increase in reported cases of PAPV in animals and humans. This study describes TaqMan based real-time PCR assays for both generic and specific detection of PAPV species for surveillance and outbreak investigations. These assays target highly conserved PAPV RNA polymerase gene sequences and are capable of detecting three known species of PAPVs (ORFV, PCPV, and BPSV). The assays were evaluated using a panel of PAPV DNA derived from human infections or animal specimen remainders. The sensitivities of all four assays were determined using droplet digital PCR; fewer than 10 copies of clinical PAPV DNA can be detected consistently. These assays provide a reliable and sensitive method for rapid confirmation and characterization PAPV infections with varying clinical presentations.


Journal of Virological Methods | 2010

Real-time PCR assays for the specific detection of monkeypox virus West African and Congo Basin strain DNA

Yu Li; Hui Zhao; Kimberly Wilkins; Christine M. Hughes; Inger K. Damon

Orthopoxvirus monkeypox (MPXV) forms two distinct clades: the MPXV Congo Basin clade viruses are endemic in the Congo Basin, human illness typically presents with symptoms similar to discrete, ordinary smallpox and has a case fatality rate of approximately 10% in unvaccinated populations; the MPXV West African clade viruses have been isolated in West Africa and appear to cause a less severe, and less inter-human transmissible disease. Recently, monkeypox outbreaks were reported in US and Sudan caused by MPXV West African and Congo Basin strains respectively. These events demonstrated the ability and trend of the virus to exploit new hosts and emerge globally; it also emphasizes the need for the diagnosis of MPXV, especially the ability to distinguish between Congo Basin and West African monkeypox strains. In this study, three new real-time PCR assays based on TaqMan probe technology were reported: the MPXV West African specific, Congo Basin strain specific and MPXV generic assays. The new assays demonstrated good specificity and sensitivity in the validation study with multiple platforms and various PCR reagent kits, and will improve the rapid detection and differentiation of monkeypox infections from other rash illness.


The Journal of Infectious Diseases | 2012

Investigation of the First Laboratory-Acquired Human Cowpox Virus Infection in the United States

Andrea M. McCollum; Connie Austin; John Nawrocki; Julia Howland; Julie Pryde; Awais Vaid; David W. Holmes; M. Ryan Weil; Yu Li; Kimberly Wilkins; Hui Zhao; Scott K. Smith; Kevin L. Karem; Mary G. Reynolds; Inger K. Damon

BACKGROUND Cowpox virus is an Orthopoxvirus that can cause infections in humans and a variety of animals. Infections occur in Eurasia; infections in humans and animals have not been reported in the United States. This report describes the occurrence of the first known human case of laboratory-acquired cowpox virus infection in the United States and the ensuing investigation. METHODS The patient and laboratory personnel were interviewed, and laboratory activities were reviewed. Real-time polymerase chain reaction (PCR) and serologic assays were used to test the patients specimens. PCR assays were used to test specimens obtained during the investigation. RESULTS A specimen from the patients lesion tested positive for cowpox virus DNA. Genome sequencing revealed a recombinant region consistent with a strain of cowpox virus stored in the research laboratorys freezer. Cowpox virus contamination was detected in 6 additional laboratory stocks of viruses. Orthopoxvirus DNA was present in 3 of 20 environmental swabs taken from laboratory surfaces. CONCLUSIONS The handling of contaminated reagents or contact with contaminated surfaces was likely the mode of transmission. Delays in recognition and diagnosis of this infection in a laboratory researcher underscore the importance of a thorough patient history-including occupational information-and laboratory testing in facilitating a prompt investigation and application of control and remediation measures.


Emerging Infectious Diseases | 2017

Detection and Molecular Characterization of Zoonotic Poxviruses Circulating in the Amazon Region of Colombia, 2014

José Aldemar Usme-Ciro; Andrea Paredes; Diana Walteros; Erica Natalia Tolosa-Pérez; Katherine Laiton-Donato; Maria del Carmen Pinzón; Brett W. Petersen; Nadia F. Gallardo-Romero; Yu Li; Kimberly Wilkins; Whitni Davidson; Jinxin Gao; Nishi Patel; Yoshinori Nakazawa; Mary G. Reynolds; Panayampalli Subbian Satheshkumar; Ginny L. Emerson; Andrés Páez-Martínez

During 2014, cutaneous lesions were reported in dairy cattle and farmworkers in the Amazon Region of western Colombia. Samples from 6 patients were analyzed by serologic and PCR testing, and results demonstrated the presence of vaccinia virus and pseudocowpox virus. These findings highlight the need for increased poxvirus surveillance in Colombia.


American Journal of Tropical Medicine and Hygiene | 2013

Detection of Human Monkeypox in the Republic of the Congo Following Intensive Community Education

Mary G. Reynolds; Ginny L. Emerson; Elisabeth Pukuta; Stomy Karhemere; Jean Jacques Muyembe; Alain Bikindou; Andrea M. McCollum; Cynthia Moses; Kimberly Wilkins; Hui Zhao; Inger K. Damon; Kevin L. Karem; Yu Li; Darin S. Carroll; Jean V. Mombouli

Monkeypox is an acute viral infection with a clinical course resembling smallpox. It is endemic in northern and central Democratic Republic of the Congo (DRC), but it is reported only sporadically in neighboring Republic of the Congo (ROC). In October 2009, interethnic violence in northwestern DRC precipitated the movement of refugees across the Ubangi River into ROC. The influx of refugees into ROC heightened concerns about monkeypox in the area, because of the possibility that the virus could be imported, or that incidence could increase caused by food insecurity and over reliance on bush meat. As part of a broad-based campaign to improve health standards in refugee settlement areas, the United Nations International Childrens Emergency Fund (UNICEF) sponsored a program of intensive community education that included modules on monkeypox recognition and prevention. In the 6 months immediately following the outreach, 10 suspected cases of monkeypox were reported to health authorities. Laboratory testing confirmed monkeypox virus infection in two individuals, one of whom was part of a cluster of four suspected cases identified retrospectively. Anecdotes collected at the time of case reporting suggest that the outreach campaign contributed to detection of suspected cases of monkeypox.


Emerging Infectious Diseases | 2013

Novel Poxvirus in Big Brown Bats, Northwestern United States

Ginny L. Emerson; Robert W. Nordhausen; Michael M. Garner; John R. Huckabee; Steven Johnson; Ron D. Wohrle; Whitni Davidson; Kimberly Wilkins; Yu Li; Jeffrey B. Doty; Nadia F. Gallardo-Romero; Maureen G. Metcalfe; Kevin L. Karem; Inger K. Damon; Darin S. Carroll

A wildlife hospital and rehabilitation center in northwestern United States received several big brown bats with necrosuppurative osteomyelitis in multiple joints. Wing and joint tissues were positive by PCR for poxvirus. Thin-section electron microscopy showed poxvirus particles within A-type inclusions. Phylogenetic comparison supports establishment of a new genus of Poxviridae.


Clinical Infectious Diseases | 2017

Novel Orthopoxvirus Infection in an Alaska Resident

Yuri P. Springer; Christopher H. Hsu; Zachary R. Werle; Link E. Olson; Michael P. Cooper; Louisa Castrodale; Nisha Fowler; Andrea M. McCollum; Cynthia S. Goldsmith; Ginny L. Emerson; Kimberly Wilkins; Jeffrey B. Doty; Jillybeth Burgado; Jinxin Gao; Nishi Patel; Matthew R. Mauldin; Mary G. Reynolds; Panayampalli Subbian Satheshkumar; Whitni Davidson; Yu Li; Joe McLaughlin

Summary A resident of interior Alaska, was diagnosed with an Orthopoxvirus infection. Phylogenetic analysis revealed it is a novel, previously undescribed Orthopoxvirus species. Phylogenetically, the virus is sister to recognized Old World orthopoxviruses, rather than North American Orthopoxvirus species.


Emerging Infectious Diseases | 2014

Poxvirus Viability and Signatures in Historical Relics

Andrea M. McCollum; Yu Li; Kimberly Wilkins; Kevin L. Karem; Whitni Davidson; Christopher D. Paddock; Mary G. Reynolds; Inger K. Damon

Although it has been >30 years since the eradication of smallpox, the unearthing of well-preserved tissue material in which the virus may reside has called into question the viability of variola virus decades or centuries after its original occurrence. Experimental data to address the long-term stability and viability of the virus are limited. There are several instances of well-preserved corpses and tissues that have been examined for poxvirus viability and viral DNA. These historical specimens cause concern for potential exposures, and each situation should be approached cautiously and independently with the available information. Nevertheless, these specimens provide information on the history of a major disease and vaccination against it.


Emerging Infectious Diseases | 2011

Secondary and Tertiary Transmission of Vaccinia Virus from US Military Service Member

Gregory E. Young; Christina M. Hidalgo; Ann Sullivan-Frohm; Cynthia Schulte; Stephen Davis; Cassandra Kelly-Cirino; Christina Egan; Kimberly Wilkins; Ginny L. Emerson; Kimberly Noyes; Debra Blog

During February and March 2010, the New York State Department of Health investigated secondary and tertiary vaccinia contact transmission from a military vaccinee to 4 close contacts. Identification of these cases underscores the need for strict adherence to postvaccination infection control guidance to avoid transmission of the live virus.

Collaboration


Dive into the Kimberly Wilkins's collaboration.

Top Co-Authors

Avatar

Yu Li

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Inger K. Damon

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Ginny L. Emerson

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Mary G. Reynolds

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Andrea M. McCollum

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Darin S. Carroll

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Kevin L. Karem

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Whitni Davidson

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Hui Zhao

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Jinxin Gao

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge